You have 9 free searches left this month | for more free features.

Leptomeningeal Metastasis

Showing 26 - 50 of 1,827

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leptomeningeal Metastases, Leptomeningeal Disease Trial in Tampa (Avelumab, Whole Brain Radiotherapy)

Active, not recruiting
  • Leptomeningeal Metastases
  • Leptomeningeal Disease
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 19, 2022

Breast Cancer Female, Leptomeningeal Metastases Trial in Charlottesville (HER2 BATs)

Terminated
  • Breast Cancer Female
  • Leptomeningeal Metastases
  • HER2 BATs
  • Charlottesville, Virginia
    University of Virginia
Dec 15, 2022

Brain Metastases, Adult Trial in Rozzano (Silibinin)

Recruiting
  • Brain Metastases, Adult
  • Silibinin
  • Rozzano, Milano, Italy
    IRCCS Humanitas Research Hospital
Mar 20, 2023

Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Patritumab deruxtecan
  • (no location specified)
May 9, 2023

NSCLC With EGFR T790M Mutation, With Brain and/or Leptomeningeal Metastasis, Failed Tyrosine Kinase Inhibitors Trial in Seoul

Active, not recruiting
  • Non-Small Cell Lung Cancer With EGFR T790M Mutation
  • +2 more
  • Seoul, Korea, Republic of
    Department of Medicine, Samsung Medical Center, Sungkyunkwan Uni
Aug 8, 2021

Leptomeningeal Metastasis, Lung Cancer Trial in Hebei (Nimotuzumab)

Recruiting
  • Leptomeningeal Metastasis
  • Lung Cancer
  • Hebei, Shijiazhuang/hebei, China
  • +1 more
Apr 18, 2021

Non Small Cell Lung Cancer Metastatic, Leptomeningeal Metastasis, Brain Metastases Trial in France (Osimertinib)

Recruiting
  • Non Small Cell Lung Cancer Metastatic
  • +3 more
  • Aix-en-Provence, France
  • +36 more
Jun 28, 2022

NSCLC, Leptomeningeal Metastases, Brain Metastases Trial in United States (Tesevatinib)

Completed
  • Non-Small Cell Lung Cancer
  • +2 more
  • Beverly Hills, California
  • +6 more
Mar 7, 2022

Leptomeningeal Metastasis, Durvalumab Trial (Durvalumab, methotrexate)

Not yet recruiting
  • Leptomeningeal Metastasis
  • Durvalumab
  • (no location specified)
May 22, 2020

Circulating Tumor DNA in Cerebrospinal Fluid asEarly Biomarker

Completed
  • Leptomeningeal Metastasis
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Aug 14, 2020

    Leptomeningeal Metastasis Trial (Recombinant Human Endostatin, intrathcal methotrexate, Targeted drugs for non-small cell lung

    Not yet recruiting
    • Leptomeningeal Metastasis
    • Recombinant Human Endostatin
    • +2 more
    • (no location specified)
    May 23, 2020

    Neuroblastoma, CNS Metastases, Leptomeningeal Metastases Trial in Worldwide (131I-omburtamab)

    Recruiting
    • Neuroblastoma
    • +2 more
    • 131I-omburtamab
    • Los Angeles, California
    • +11 more
    Dec 17, 2021

    Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)

    Completed
    • Brain and Central Nervous System Tumors
    • +10 more
    • Chicago, Illinois
      Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
    Sep 3, 2021

    Meningeal Carcinomatosis Trial in Amsterdam (lumbar puncture)

    Completed
    • Meningeal Carcinomatosis
    • lumbar puncture
    • Amsterdam, Netherlands
    • +1 more
    Jan 19, 2021

    Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Dexamethasone, Radiotherapy)

    Completed
    • Leptomeningeal Metastasis
    • Changchun, Jilin, China
      The First Hospital of Jilin University
    Dec 23, 2019

    Leptomeningeal Carcinomatosis Trial in Boston (Nivolumab, Ipilimumab)

    Active, not recruiting
    • Leptomeningeal Carcinomatosis
    • Boston, Massachusetts
    • +1 more
    Sep 4, 2020

    Leptomeningeal Metastasis Trial in Beijing (tomotherapy)

    Completed
    • Leptomeningeal Metastasis
    • tomotherapy
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences
    Nov 25, 2019

    Leptomeningeal Metastasis, NSCLC, EGFR Activating Mutation Trial (Osimertinib, Bevacizumab)

    Unknown status
    • Leptomeningeal Metastasis
    • +2 more
    • (no location specified)
    Nov 1, 2019

    Brain Metastases, Adult Trial in Switzerland (preoperative radiosurgery, postoperative hypofractionated stereotactic

    Recruiting
    • Brain Metastases, Adult
    • preoperative radiosurgery
    • postoperative hypofractionated stereotactic radiotherapy
    • Aarau, Aargau, Switzerland
    • +5 more
    Sep 7, 2022

    Leptomeningeal Metastasis Trial in Changchun (MTX, Ara-C, Radiotherapy)

    Completed
    • Leptomeningeal Metastasis
    • Changchun, Jilin, China
      The First Hospital of Jilin University
    Jul 30, 2019

    Brain Metastases, Adult Trial in Pittsburgh (Pre-operative Stereotactic Radiosurgery)

    Recruiting
    • Brain Metastases, Adult
    • Pre-operative Stereotactic Radiosurgery
    • Pittsburgh, Pennsylvania
      Allegheny General Hospital
    Apr 18, 2022

    EGFR Mutation Positive Advanced Non Small Cell Lung Cancer Trial in Worldwide (AZD3759, AZD9291)

    Completed
    • EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
    • Los Angeles, California
    • +9 more
    Jan 4, 2021

    Leptomeningeal Metastases Trial in Changchun (Pemetrexed, Dexamethasone, Folic Acid)

    Completed
    • Leptomeningeal Metastases
    • Changchun, Jilin, China
      The First Hospital of Jilin University
    Mar 16, 2019

    Brain Metastases Trial in Indianapolis (Radiosurgery)

    Active, not recruiting
    • Brain Metastases
    • Radiosurgery
    • Indianapolis, Indiana
    • +2 more
    Jun 8, 2022